1. Song X*, Wang P, Wang J, Affo S, Wang H, Xu M, Schwabe R, Chang T, Vogl M, Pes G, Ribback S, Evert M, Calvisi D*, and Chen X*.Focal Adhesion Kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation.Journal of Hepatology.2021.75(4).888-899.SCI |
2. Shang R#, Song X#, Wang P#, Lu X, Xu M, Chen X, Utpatel K, Che L, Liang B, Cigliano A, Evert M, Calvisi D*, and Chen X* .Cabozantinib based combination therapy for the treatment of Hepatocellular Carcinoma.Gut.2021.70(9).1746-1757.SCI |
3. Wang P#, Song X#, Cao D, Cui K, Wang J, Utpatel K, Shang R, Wang H, Che L, Evert M, Zhao K, Calvisi D* and Chen X*.Oncogene-dependent function of BRG1 in hepatocarcinogenesis.Cell Death & Disease.2020.11(2).91.SCI |
4. Song X, Liu X, Wang H, Wang J, Qiao Y, Cigliano A, Utpatel K, Ribback S, Pilo MG, Serra M, Gordan JD, Che L, Zhang S, Cossu A, Porcu A, Pascale RM, Dombrowski F, Hu H*, Calvisi DF, Evert M*, Chen X*.Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma.Clinical Cancer Research.2019.25(1).403-413.SCI |
5. Liu X, Hu J, Song X*, Kirsten Utpatel, Yi Zhang, Pan Wang, Xinjun Lu, Jie Zhang, Meng Xu, Tao Su, Li Che, Jingxiao Wang, Matthias Evert, Diego F. Calvisi, and Xin Chen*.Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma.Cancers(Basel).2019.11(7).930.SCI |
6. Wang P#, Song X#, Utpatel K, Shang R, Yang YM, Xu M, Zhang J, Che L, Gordan J, Cigliano A, Seki E, Evert M, Calvisi DF*, Hu X*, Chen X*.MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment.Cell Death & Disease.2019.10(2).120.SCI |